Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Acasti Pharma Inc (ACST)  
$0.40 0.00 (0.00%) as of 4:30 Mon 8/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 44,290,000
Market Cap: 17.76(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.401 - $0.401
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Acasti Pharma is a biopharmaceutical company that is focused on the research, development and commercialization of cardiometabolic prescription drugs using omega-3 (OM3) fatty acids delivered both as free fatty acids and bound-to-phospholipid esters, derived from krill oil. Co.'s primary product candidate is CaPre, an OM3 phospholipid therapeutic. Co. has one reportable operating segment: the development and commercialization of pharmaceutical applications of its patent portfolio and licensed rights for cardiovascular diseases.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 676,752 676,752
Total Buy Value $0 $0 $1,250,715 $1,250,715
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 16
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Kottayil George Director   –       •      –    2023-10-10 3 IO $0.00 $0 I/I 0 124,344     -
   Kottayil George Director   –       •      –    2023-10-10 3 IO $0.00 $0 D/D 0 370,354     -
   Kavuru Vimal Director   –       •       •   2023-09-25 4 B $1.85 $1,249,934 I/I 676,371 1,188,076 2.25     -
   Olds Donald Director   –       •      –    2023-08-31 4 B $2.05 $781 D/D 381 381 2.31     -
   Kumar Amresh VP Program ManagementOfficer   •       –      –    2023-05-08 3 IO $0.00 $0 D/D 0 66,712     -
   Kohli Prashant CCOOfficer   •       –      –    2022-09-09 3 IO $0.00 $0 D/D 0 128,138     -
   Haseltine William A Director   –       •      –    2021-08-27 3 IO $0.00 $0 D/D 0 7,105 -100%     
   Haseltine William A Director   –       •      –    2021-08-27 3 IO $0.00 $0 I/I 0 325,731 -100%     
   Kavuru Vimal Director   –       •      –    2021-08-27 3 IO $0.00 $0 I/I 0 3,816,293 -100%     
   Iyer Swami Sambamurty 10% Owner   –       –       •   2021-08-27 3 IO $0.00 $0 D/D 0 4,689,547 -100%     
   Lemieux Pierre COO & CSOOfficer   •       –      –    2020-04-01 3 IO $0.00 $0 D/D 0 7,000 88%     
   Boily Jean-Francois VICE-PRESIDENT, FINANCEOfficer   •       –      –    2020-04-01 3 IO $0.00 $0 D/D 0 10,600 88%     
   Dalvise Janelle PRESIDENT & CEOOfficer   •       •      –    2020-04-01 3 IO $0.00 $0 D/D 0 52,500 88%     
   Canan John Director   –       •      –    2020-04-01 3 IO $0.00 $0 D/D 0 100,000 88%     
   Olds Donald Director   –       •      –    2020-04-01 3 IO $0.00 $0 I/I 0 38,000 88%     
   Canan John Director   –       •      –    2017-02-21 3 IO $0.00 $0 D/D 0 40,000     -

  16 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed